Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations
Julien Mazières, Claire Cropet, Laure Montané, Fabrice Barlési, P.-J. Souquet, Xavier Quantin, Catherine Dubos‐Arvis, Josiane Otto, Laure Favier, Virginie Avrillon, J. Cadranel, Denis Moro‐Sibilot, I. Monnet, Virginie Westeel, J. Le Treut, Étienne Brain, Jean Trédaniel, M. Jaffro, S. Collot, G. Ferretti, Céline Tiffon, Céline Mahier‐Ait Oukhatar, Jean‐Yves Blay
Topics & Concepts
VemurafenibMedicineInternal medicineOncologyCohortLung cancerTrametinibDabrafenibCancerMetastatic melanomaBiologyKinaseMAPK/ERK pathwayCell biologyMelanoma and MAPK PathwaysLung Cancer Treatments and MutationsNF-κB Signaling Pathways